Compugen (CGEN)
Builds cancer immunotherapies from computationally predicted drug targets.
$2.65
Pre-market+0.03 (+1.00%)
At close$2.63(+1.35%)
Something off on this page? Send us feedback.
Next report
Nov 9, 2026
in 67 days
EPS estimate
−$0.07
Revenue estimate
$1.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.07−$0.08−$0.08−$0.07$0.60−$0.08−$0.07Pending
Estimate$0.07−$0.06−$0.07−$0.09−$0.07−$0.07−$0.08−$0.07
Surprise−200.0%−33.3%−14.3%+22.2%+957.1%−14.3%+12.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.5M$2.3M$1.3M$1.9M$67.3M$2.2M$2.6MPending
Estimate$5.0M$3.7M$1.5M$14.3M$2.2M$1.6M$1.3M$1.3M
Surprise−70.6%−38.3%−14.5%−86.8%+3,018.2%+38.5%+102.6%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.08 | −$0.07 | +12.5% |
| May 2026 | −$0.07 | −$0.08 | −14.3% |
| Mar 2026 | −$0.07 | $0.60 | +957.1% |
| Nov 2025 | −$0.09 | −$0.07 | +22.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.07 | — | — | $1.3M | — | — | — |
| Aug 3, 2026 | −$0.08 | −$0.07 | +12.5% | $1.3M | $2.6M | +102.6% | +1.3% |
| May 18, 2026 | −$0.07 | −$0.08 | −14.3% | $1.6M | $2.2M | +38.5% | −4.6% |
| Mar 2, 2026 | −$0.07 | $0.60 | +957.1% | $2.2M | $67.3M | +3,018.2% | −11.1% |
| Nov 10, 2025 | −$0.09 | −$0.07 | +22.2% | $14.3M | $1.9M | −86.8% | +3.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 6, 2025 | |||||||
| May 19, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 20, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 16, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Jul 28, 2021 | |||||||
| May 13, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Jul 30, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Nov 11, 2019 | |||||||
| Aug 5, 2019 | |||||||
| May 20, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 9, 2018 | |||||||
| Feb 21, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 15, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 10, 2016 | |||||||
| Feb 9, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Aug 4, 2015 | |||||||